5678192
Last Update Posted: 2023-06-22
Recruiting has ended
Females accepted | 45 Years-59 Years |
40 Estimated Participants | No Expanded Access |
Interventional Study | Accepts healthy volunteers |
Effect of Menopausal Hormone Therapy on Immune System Parameters
The objective of the study is to evaluate the effect of menopausal hormone therapy on the parameters of the immune system. To do this, patients took blood to assess the immune status before the start of therapy and after 3 months.
An additional task is to assess the content of blood sex hormones before the start of therapy and after 3 months.
A study of 60 perimenopausal and postmenopausal patients was included. The cohort was divided into groups depending on the treatment regimen.
Group 1 (n=20) received transdermal menopausal hormone therapy (MHT). Group 2 (n=20) received oral MHT.
Eligibility
Relevant conditions:
Last Period Not Earlier Than 6 Months Ago
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov